The New England journal of medicine, 2021-12, Vol.385 (23), p.2150-2160
- Van Mieghem, Nicolas M
- Unverdorben, Martin
- Hengstenberg, Christian
- Möllmann, Helge
- Mehran, Roxana
- López-Otero, Diego
- Nombela-Franco, Luis
- Moreno, Raul
- Nordbeck, Peter
- Thiele, Holger
- Lang, Irene
- Zamorano, José L
- Shawl, Fayaz
- Yamamoto, Masanori
- Watanabe, Yusuke
- Hayashida, Kentaro
- Hambrecht, Rainer
- Meincke, Felix
- Vranckx, Pascal
- Jin, James
- Boersma, Eric
- Rodés-Cabau, Josep
- Ohlmann, Patrick
- Capranzano, Piera
- Kim, Hyo-Soo
- Pilgrim, Thomas
- Anderson, Richard
- Baber, Usman
- Duggal, Anil
- Laeis, Petra
- Lanz, Hans
- Chen, Cathy
- Valgimigli, Marco
- Veltkamp, Roland
- Saito, Shigeru
- Dangas, George D
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Van Mieghem, Nicolas M
- Unverdorben, Martin
- Hengstenberg, Christian
- Möllmann, Helge
- Mehran, Roxana
- López-Otero, Diego
- Nombela-Franco, Luis
- Moreno, Raul
- Nordbeck, Peter
- Thiele, Holger
- Lang, Irene
- Zamorano, José L
- Shawl, Fayaz
- Yamamoto, Masanori
- Watanabe, Yusuke
- Hayashida, Kentaro
- Hambrecht, Rainer
- Meincke, Felix
- Vranckx, Pascal
- Jin, James
- Boersma, Eric
- Rodés-Cabau, Josep
- Ohlmann, Patrick
- Capranzano, Piera
- Kim, Hyo-Soo
- Pilgrim, Thomas
- Anderson, Richard
- Baber, Usman
- Duggal, Anil
- Laeis, Petra
- Lanz, Hans
- Chen, Cathy
- Valgimigli, Marco
- Veltkamp, Roland
- Saito, Shigeru
- Dangas, George D
- Titel
- Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR
- Ist Teil von
- The New England journal of medicine, 2021-12, Vol.385 (23), p.2150-2160
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a randomized trial involving patients who had atrial fibrillation after TAVR, edoxaban was noninferior to vitamin K antagonists with respect to a composite outcome of death, MI, stroke, thromboembolism, valve thrombosis, or major bleeding but was associated with a higher incidence of major bleeding.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2111016Titel-ID: cdi_proquest_miscellaneous_2566037781
- Format
- –
- Schlagworte
- 4-Hydroxycoumarins - adverse effects, 4-Hydroxycoumarins - therapeutic use, Adverse events, Aged, Aged, 80 and over, Antagonists, Anticoagulants, Anticoagulants - adverse effects, Anticoagulants - therapeutic use, Anticoagulation, Arrhythmias, Atrial Fibrillation - drug therapy, Bleeding, Cardiac arrhythmia, Cardiology, Cardiology General, Cardiovascular Surgery, Cerebral infarction, Clinical outcomes, Confidence intervals, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, Female, Fibrillation, Gastrointestinal Hemorrhage - chemically induced, Heart attacks, Humans, Intention to Treat Analysis, Ischemia, Kaplan-Meier Estimate, Male, Mortality, Myocardial infarction, Neurology, Neurosurgery, Pacemakers, Patients, Phenindione - analogs & derivatives, Phenindione - therapeutic use, Postoperative Complications - prevention & control, Pyridines - adverse effects, Pyridines - therapeutic use, Statistical analysis, Stroke, Surgery, Thiazoles - adverse effects, Thiazoles - therapeutic use, Thromboembolism, Thromboembolism - prevention & control, Thrombosis, Transcatheter Aortic Valve Replacement - adverse effects, Vitamin K, Vitamin K - antagonists & inhibitors